Celebrating its 25th anniversary, NICE hosted a conference looking back at its progress and ahead to...
Read moreThe advent of cell and gene therapies (CGTs) represents a paradigm shift in medicine, offering the p...
Read moreThere is no excerpt because this is a protected post.
Read moreThe population, intervention, comparator, and outcomes (PICO) element of the upcoming EU Joint Clini...
Read moreWe were thrilled to attend the World Evidence, Pricing and Access Congress (World EPA) in Amsterdam ...
Read moreCharlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c...
Read moreAUTHORS: Joyce Atim, Rahul Vadehra Rare diseases have a significant impact on people worldwide...
Read moreEU HTA Regulation goes live: A new era for HTA begins The much-awaited implementation of the r...
Read moreOur review of the 2024 pricing and market access revealed key challenges facing the pharmaceutical i...
Read moreRemap Consulting presents ground-breaking insights and practical learnings from one of the pioneerin...
Read more